Inicio>>Analytical Standards>> Certified Reference Materials>>N,N-didesmethyl U-47700 (trifluoroacetate salt) (CRM)

N,N-didesmethyl U-47700 (trifluoroacetate salt) (CRM) (Synonyms: nor-U-47700, N,N-didesethyl U-49900)

Catalog No.GC48798

Products are for research use only. Not for human use. We do not sell to patients.

N,N-didesmethyl U-47700 (trifluoroacetate salt) (CRM) Chemical Structure

Cas No.: 2708579-41-1

Tamaño Precio Disponibilidad Cantidad
1mg
335,00 $
Disponible

Tel:(909) 407-4943 Email: sales@glpbio.com


Reseñas de cliente

Based on customer reviews.

  • GlpBio Citations

    GlpBio Citations
  • Bioactive Compounds Premium Provider

    Bioactive Compounds Premium Provider

Sample solution is provided at 25 µL, 10mM.

Description Chemical Properties Product Documents Related Products

N,N-didesmethyl U-47700 (trifluoroacetate salt) is a certified reference material categorized as an opioid.1,2 It is a known metabolite of U-47700 . N,N-didesmethyl U-47700 is also known as N,N-didesethyl U-49900 because it is also a known metabolite of U-49900 .2 This product is intended for research and forensic applications.

1.Elliott, S.P., Brandt, S.D., and Smith, C.The first reported fatality associated with the synthetic opioid 3,4-dichloro-N-[2-(dimethylamino)cyclohexyl]-N-methylbenzamide (U-47700) and implications for forensic analysisDrug Test Anal.8(8)875-879(2016) 2.Krotulski, A.J., Mohr, A.L.A., Papsun, D.M., et al.Metabolism of novel opioid agonists U-47700 and U-49900 using human liver microsomes with confirmation in authentic urine specimens from drug usersDrug Test Anal.10(1)127-136(2018)

Reseñas

Review for N,N-didesmethyl U-47700 (trifluoroacetate salt) (CRM)

Average Rating: 5 ★★★★★ (Based on Reviews and 38 reference(s) in Google Scholar.)

5 Star
100%
4 Star
0%
3 Star
0%
2 Star
0%
1 Star
0%
Review for N,N-didesmethyl U-47700 (trifluoroacetate salt) (CRM)

GLPBIO products are for RESEARCH USE ONLY. Please make sure your review or question is research based.

Required fields are marked with *

You may receive emails regarding this submission. Any emails will include the ability to opt-out of future communications.